Caxton Corporation’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Caxton Corporation’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-200,000	Closed	-$1.96M	–	50
2021 Q4	$1.96M	Hold	200,000	–	–	1.6%	12
2021 Q3	$1.96M	Hold	200,000	–	–	1.59%	12
2021 Q2	$1.98M	Hold	200,000	–	–	1.36%	12
2021 Q1	$2.05M	Buy	+200,000	New	+$2.22M	1.33%	12

Other funds holding LUXA

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

Wolfswood Holdings New York $2.84M AUM 30.46% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

SIG

Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RIA

RP Investment Advisors Toronto, Ontario, Canada $900K AUM 17.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Caxton Corporation's LUXA Position: Q1 2022 in Review

Caxton Corporation sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q1 2022, closing a stake of 200,000 shares — an estimated $1.96M sold.

Caxton Corporation first reported a position in LUXA in Q1 2021 and held it in 4 quarters. The position peaked at $2.05M in Q1 2021. 65 funds tracked by Wall St. Rank hold LUXA as of Q1 2022.

Caxton Corporation reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
Caxton Corporation sold 200,000 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q1 2022, an estimated $1.96M.
Caxton Corporation first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 4 quarters.
Caxton Corporation's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $2.05M in Q1 2021.
65 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q1 2022.

Based on Caxton Corporation's 13F filing for Q1 2022, filed 16 May 2022.